{"schema_version":"secwatch.filing_event.v1","accession":"0000920148-26-000182","form_type":"8-K","ticker":"LH","cik":"0000920148","company_name":"LABCORP HOLDINGS INC.","filed_at":"2026-08-14T12:55:14+00:00","discovered_at":"2026-08-14T13:00:00.303522+00:00","generated_at":"2026-08-14T13:00:05.163589+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Labcorp EVP Bailey resigns; Caveney to lead Biopharma Lab Services","bullets":["Megan D. Bailey resigns as EVP & President, Central Laboratories and International, effective Sept 4, 2026.","Brian J. Caveney, M.D. becomes EVP & President, Biopharma Laboratory Services and Chief Medical & Scientific Officer on Sept 1, 2026.","Caveney will oversee Early Development Research Laboratories and Central Laboratories businesses.","Caveney previously led Early Development Research Laboratories and served as Chief Medical and Scientific Officer."],"urls":{"canonical":"https://secwatch.observer/filing/0000920148-26-000182","json":"https://secwatch.observer/filing/0000920148-26-000182.json","markdown":"https://secwatch.observer/filing/0000920148-26-000182.md","text":"https://secwatch.observer/filing/0000920148-26-000182.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000182/0000920148-26-000182-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/920148/000092014826000182/lh-20260811.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-14T13:00:05.163589+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}